A probiotic bacterium whose most consistent evidence is in the mouth — fresher breath and modestly healthier gums within weeks. Smaller results support preventing a pregnancy infection and breast inflammation while breastfeeding, plus immune support. Uses for allergies, fertility, mood, and blood sugar remain early. Low risk overall, though effects differ by strain. (Full Review)

Protocol

Dose

1–10 billion CFU/day

Named strain; lozenges for oral goals, capsules for gut and immune goals

Timing

With or after a meal

Gut and immune goals; oral strains after brushing at night, then avoid eating or drinking

Frequency

Daily, continuous

Transient — cleared 1–2 weeks after stopping; oral lozenges 1–3× daily

Time to effect

Breath odor

2–4 weeks

Clearest within four weeks, less durable thereafter

Gum health

~2 months

Gingival improvement over two months

Immune & gut effects

Several weeks

Build gradually with continuous use

Benefits

High: Reduction of oral malodor

Medium: Improved periodontal and gingival health; prevention of lactational mastitis

Low: Reduced Group B Streptococcus colonization in pregnancy; immune modulation and mucosal defense

Speculative: Support for allergic and atopic conditions; enhanced fertility in unexplained infertility; metabolic and cellular-aging support; inhibition of oral carcinogenesis

Contraindications

Severe immunosuppression

Critical illness

Central venous catheters

Short-bowel syndrome

Prosthetic or damaged heart valves

Preterm neonates (except specialized neonatal protocols)

Key Interactions

Antibiotics (amoxicillin, azithromycin, ciprofloxacin)

Immunosuppressants (tacrolimus, cyclosporine, high-dose corticosteroids, chemotherapy)

Antifungal and antibacterial mouth rinses (chlorhexidine)

Risk & Side Effects

High: Mild, transient gastrointestinal symptoms

Medium: Systemic infection in vulnerable hosts

Low: Antibiotic-resistance gene carriage or transfer

Speculative: D-lactic acidosis in short-bowel syndrome; excessive or unwanted immune modulation

Monitoring

Marker	Target	Why
Breath-odor (organoleptic) score	0–1 on a 0–5 scale	Tracks halitosis response
Volatile sulfur compounds (VSC)	< 150 ppb total	Objective breath-odor marker
Fecal calprotectin	< 20 µg/g (functional); < 50 conventional	Gut inflammation
hs-CRP (high-sensitivity C-reactive protein)	< 1.0 mg/L	Systemic inflammation
Salivary secretory IgA (immunoglobulin A)	Within lab reference; trend upward if low	Mucosal immune tone
Glycated hemoglobin (HbA1c)	< 5.4% (functional); < 5.7% conventional	Glycemic control (metabolic goal only)

Cadence: Goal-matched baseline before starting; reassess at 4 weeks and 8–12 weeks, then every 6–12 months if use continues

Qualitative Assessment

Freshness of breath and confidence in close conversation
Gum comfort and reduced bleeding when brushing or flossing
Digestive comfort — less bloating, more regularity
General energy and sense of wellbeing
Frequency and severity of minor upper-respiratory or oral infections

Lactobacillus salivarius for Health & Longevity

Protocol

Benefits

Risk & Side Effects

Monitoring

Qualitative Assessment